Intensity Therapeutics, Inc. (INTS) financial statements and ratios from SEC XBRL: revenue $180000.00 (TTM), net margin -6447.8%, revenue growth -42.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $180000.00 |
| Net Margin | -6447.8% |
| Revenue Growth (YoY) | -42.7% |
| EPS Growth (YoY) | 631.6% |
| Price / Book | 1.72 |
| Price / Sales | 49.02 |
| Altman Z-Score | -6.34 (distress) |
| Sector P/E (Healthcare) | 21.7 |
INTS overview · INTS earnings · INTS KPIs · INTS investor relations · INTS ownership · INTS peers · INTS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.